Photodynamic therapy for cholangiocarcinoma

Seminars in Liver Disease

Volumn 24, Issue 2, 2004, Pages 177-187

  Berr, Frieder ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

Author keywords

Bile duct cancer; Cholangiocarcinoma; Hematoporphyrin derivative; Photodynamic therapy; Photosensitizer; Porfimer sodium

Indexed keywords

BLEOMYCIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN; PHOTOSENSITIZING AGENT;

BILE DUCT CARCINOMA; BILE DUCT PROSTHESIS; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CHOLANGITIS; CHOLESTASIS; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HUMAN; INOPERABLE CANCER; LASER; LIVER FAILURE; METASTASIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; STENT; SUNBURN; SURVIVAL TIME; TUMOR GROWTH;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DIHEMATOPORPHYRIN ETHER; HEMATOPORPHYRIN PHOTORADIATION; HUMANS; PALLIATIVE CARE; QUALITY OF LIFE; STENTS; SURVIVAL RATE;

EID: 2942529179     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-828894     Document Type: Review

References (65)

1. de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med 1999;341:1368-1378 (Review)
2. Gores GJ. Cholangiocarcinoma: current concepts and insights. Hepatology 2003;37:961-969 (Review)
3. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38:241-256
4. Bismuth H, Nakache R, Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 1992; 215:31-38
5. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade and survival rates. Cancer 1992;70:1498-1501
6. Kimura W, Nagai H, Atomi Y, et al. Clinico-pathological characteristics of hepatic hilar bile duct carcinoma. Hepatogastroenterology 1993;40:21-27
7. McCaughan JS, Mertens BF, Cho C, Barabash RD, Payton HW. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 1991;126:111-113
8. Ortner MA, Liebetruth J, Schreiber S, et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 1998;114:536-542
9. Berr F, Tannapfel A, Lamesch P, et al. Neoadjuvant therapy before curative resection of proximal bile duct carcinoma (case report). J Hepatol 2000;32:352-357
10. Berr F, Wiedmann M, Tannapfel A, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000;31:291-298
11. Rumalla A, Baron T, Wang K, et al. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 2001;53:500-504
12. Zoepf T, Jakobs R, Arnold JC, et al. Photodynamic therapy for palliation of nonresectable bile duct cancer-preliminary results with a new diode laser system. Am J Gastroenterol 2001;96:2093-2097
13. Dumoulin FL, Gerhardt T, Fuchs S, et al. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma. Gastrointest Endosc 2003;57:860-867
14. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003;125:1355-1363
15. Wiedmann M, Caca K, Berr F, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma. Cancer 2003;97:2783-2790
16. Davids PHP, Groen AK, Rauws EAJ, et al. Randomised trial of self-expanding metal stents versus polyethylene stents for malignant distal biliary obstruction. Lancet 1992;340:1488-1492
17. Murad AM, Guimaraes RC, Aragao BC, et al. Phase II trial of the use of gemcitabine and 5-fluorouracil in the treatment of advanced pancreatic and biliary tract cancer. Am J Clin Oncol 2003;26:151-155
18. Whittington R, Neuberg D, Tesfer WJ, et al. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreatobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol 1995;13:227-232
19. Burke EC, Jarnagin ER, Hochwald SN, et al. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-394
20. Neuhaus P, Jonas S, Bechstein WO, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808-819
21. Pichlmayr R, Weimann A, Klempnauer J, et al. Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg 1996;224: 628-638 (Review)
22. Madriaga JR, Iwatsuki S, Todo S, et al. Liver resection for hilar and peripheral cholangiocarcinoma: a study of 62 cases. Ann Surg 1998;227:70-90
23. Launois B, Terblanche J, Lakehal M, et al. Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 1999;230:266-275
24. Kosuge T, Yamamoto J, Shimada K, et al. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 1999;230:663-671
25. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-517
26. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after non-curative intervention. Mayo Clin Proc 1995;70:425-429
27. Devière J, Baize M, de Toeuf J, Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 1988;34:95-101
28. Polydorou AA, Cairns SR, Dowsett JF, et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991;32:685-689
29. Ducreux M, Liguory C, Lefebvre JF, et al. Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 1992;37:778-783
30. Liu C-L, Lo C-M, Lai ECS, Fan S-T. Endoscopic retrograde cholangiopancreato-graphy and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg 1998;133:293-296
31. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-362
32. Molt P, Hopfan S, Watson R, et al. Intraluminal radiation therapy in the management of malignant biliary obstruction. Cancer 1986;57:536-544
33. Kamada T, Saitou H, Takamura A, Nojima T, Okushiba SI. The role of radiotherapy in the management of extrahepatic bile duct cancer: an analysis of 145 consecutive patients treated with intraluminal and/or external beam radiotherapy. Int J Radiat Oncol Biol Physiol 1996;34:767-774
34. Bowling TE, Galbraith SM, Hatfield ARW, et al. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996;39:852-855
35. Ede RJ, Williams SJ, Hatfield ARW, et al. Endoscopic management of inoperable cholangiocarcinoma using iridium-192. Br J Surg 1989;76:867-869
36. Tsujino K, Landry JC, Smith RG, et al. Definitive radiation therapy for extrahepatic bile duct carcinoma. Radiology 1995; 196:275-280
37. Kuvshinoff BW, Armstrong JG, Fong Y, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995;82:1522-1525
38. Eschelman DJ, Shapiro MJ, Bonn J, et al. Malignant biliary obstruction: Long-term experience with Gianturco stents and combined-modality radiation therapy. Radiology 1996;200:717-724
39. Foo ML, Gunderson LL, Bender CE, Buskirk SJ. External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Physiol 1997;39:929-935 (Review)
40. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy (review). J Natl Cancer Inst 1998;90:889-904
41. Hsi RA, Rosenthal DI, Glatstein E. Photodynamic therapy in the treatment of cancer: current state of the art. Drugs 1999; 57:725-734 (Review)
42. Hayata Y, Kato H, Konaka C, et al. Hematoporphyrin derivative and photoradiation therapy in early-stage lung cancer. Lasers Surg Med 1984;4:39-47
43. Prout GR, Lin CW, Benson RJ, et al. Photodynamic therapy of superficial transitional cell carcinoma of the bladder. N Engl J Med 1987;317:1251-1255
44. Edell E, Cortese D. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992;102:1319-1322
45. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995;108:337-344
46. Overholt B, Panjehpour M, Haydek J. Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest Endosc 1999;49:1-7
47. Wong Kee Song LM, Wang KK, Zinsmeister AR. Mono-L-aspartyl chlorine 6 and hematoporphyrin derivative in photodynamic therapy administered to a human cholangiocarcinoma model. Cancer 1998;82:421-427
48. Oertel M, Schastak SI, Tannapfel A, et al. Novel bacteriochlorine for high tissue-penetration: photodynamic properties in human biliary tract cancer cells in vitro and in a mouse tumour model. J Photochem Photobiol B 2003;71:1-10
49. Pahernik SA, Dellian M, Berr F, et al. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 1998;47:58-62
50. Zoepf T, Jakobs R, Rosenbaum A, et al. Photodynamic therapy with 5-amino-levulinic acid is not effective in bile duct cancer. Gastrointest Endosc 2001;54:763-766
51. Schoefl R, Haefner M, Wrba F, et al. Forceps biopsy and brush cytology during endoscopic retrograde cholangiopancreatography for the diagnosis of biliary stenoses. Scand J Gastroent 1997;32:363-368
52. Kluge R, Schmidt F, Caca K, et al. Positron emission tomography with [18F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001;33:1029-1035
53. Lai ECS, Patterson IA, Tam PC, et al. Severe acute cholangitis: The role for emergency nasobiliary drainage. World J Surg 1990;107:268-272
54. Lai ECS, Mok EPT, Tan ESY, et al. Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med 1992;326:1582-1586
55. Gores GJ. A spotlight on cholangiocarcinoma. Gastroenterology 2003;125:1536-1538 (Review)
56. Born P, Rösch T, Willkomm G, et al. Initial experience with a new Yamakawa-type prosthesis for long-term percutaneous transhepatic drainage. Endoscopy 1999;31:748-750
57. Peters RA, Williams SG, Lombard M, Karani J, Westaby D. The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses. Endoscopy 1997;29:10-16
58. Bown SG, Rogowska AZ, Whitelaw DE, et al. Photodynamic therapy for cancer of the pancreas. Gut 2002;50:549-557
59. Schiefke I, Zabel-Langhennig A, Wiedmann M, et al. Self-expandable metallic stents for malignant duodenal obstruction caused by biliary tract cancer. Gastrointest Endosc 2003;58:213-219
60. Saltz LB, Cox JV, Blanke C, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-914
61. Rothenberg ML, Oza AM, Bigelow RH, et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial. J Clin Oncol 2003;21:2059-2063
62. Wiedmann M, Berr F, Schlefke J, et al. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma: 5-year follow-up of a prospective phase II study. Gastrointest Endosc 2004;59 (in press)
63. DeVreede I, Steers JL, Burch PA, et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 2000;6:309-316
64. Sudan D, DeRoover A, Chinnakotia S, et al. Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2002;2:774-779
65. Kaya M, de Groen PC, Angulo P, et al. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience. Am J Gastroenterol 2001; 96:1164-1169